Annual EBIT
-$63.32 M
+$727.70 K+1.14%
December 31, 2024
Summary
- As of March 10, 2025, SLN annual earnings before interest & taxes is -$63.32 million, with the most recent change of +$727.70 thousand (+1.14%) on December 31, 2024.
- During the last 3 years, SLN annual EBIT has fallen by -$1.44 million (-2.33%).
- SLN annual EBIT is now -4291.97% below its all-time high of -$1.44 million, reached on December 31, 1995.
Performance
SLN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.66 M
+$22.18 M+76.90%
December 1, 2024
Summary
- As of March 10, 2025, SLN quarterly earnings before interest & taxes is -$6.66 million, with the most recent change of +$22.18 million (+76.90%) on December 1, 2024.
- Over the past year, SLN quarterly EBIT has stayed the same.
- SLN quarterly EBIT is now -57.46% below its all-time high of -$4.23 million, reached on March 31, 2024.
Performance
SLN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$61.57 M
+$14.38 M+18.93%
December 1, 2024
Summary
- As of March 10, 2025, SLN TTM earnings before interest & taxes is -$61.57 million, with the most recent change of +$14.38 million (+18.93%) on December 1, 2024.
- Over the past year, SLN TTM EBIT has stayed the same.
- SLN TTM EBIT is now -408.05% below its all-time high of -$12.12 million, reached on September 30, 2020.
Performance
SLN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.1% | 0.0% | 0.0% |
| 3 y3 years | -2.3% | 0.0% | 0.0% |
| 5 y5 years | -111.5% | 0.0% | 0.0% |
SLN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +1.1% | -57.5% | +76.9% | -17.7% | +18.9% |
| 5 y | 5-year | -111.5% | +1.1% | -57.5% | +76.9% | -408.1% | +18.9% |
| alltime | all time | -4292.0% | +1.1% | -57.5% | +76.9% | -408.1% | +18.9% |
Silence Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$63.32 M(-1.1%) | - | - |
| Dec 2024 | - | -$6.66 M(-76.9%) | -$61.57 M(-18.9%) |
| Sep 2024 | - | -$28.85 M(+32.2%) | -$75.95 M(+26.4%) |
| Jun 2024 | - | -$21.83 M(+415.8%) | -$60.10 M(+14.9%) |
| Mar 2024 | - | -$4.23 M(-79.9%) | -$52.29 M(-16.6%) |
| Dec 2023 | -$64.05 M(+11.8%) | -$21.04 M(+61.9%) | -$62.69 M(-0.3%) |
| Sep 2023 | - | -$13.00 M(-7.3%) | -$62.87 M(+4.4%) |
| Jun 2023 | - | -$14.02 M(-4.2%) | -$60.25 M(-3.6%) |
| Mar 2023 | - | -$14.63 M(-31.0%) | -$62.50 M(+3.4%) |
| Dec 2022 | -$57.27 M(-7.5%) | -$21.22 M(+104.5%) | -$60.44 M(+10.5%) |
| Sep 2022 | - | -$10.38 M(-36.3%) | -$54.72 M(-9.5%) |
| Jun 2022 | - | -$16.28 M(+29.5%) | -$60.44 M(-2.1%) |
| Mar 2022 | - | -$12.57 M(-18.9%) | -$61.76 M(-0.4%) |
| Dec 2021 | -$61.88 M(+26.0%) | -$15.50 M(-3.7%) | -$62.02 M(-6.5%) |
| Sep 2021 | - | -$16.10 M(-8.5%) | -$66.35 M(+6.4%) |
| Jun 2021 | - | -$17.59 M(+37.0%) | -$62.37 M(+39.3%) |
| Mar 2021 | - | -$12.84 M(-35.3%) | -$44.79 M(+40.2%) |
| Dec 2020 | -$49.10 M(+64.0%) | -$19.83 M(+63.6%) | -$31.95 M(+163.6%) |
| Sep 2020 | - | -$12.12 M | -$12.12 M |
| Dec 2019 | -$29.94 M(+15.0%) | - | - |
| Dec 2018 | -$26.05 M(+412.6%) | - | - |
| Dec 2017 | -$5.08 M(-65.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$14.69 M(+1.5%) | - | - |
| Dec 2015 | -$14.47 M(-23.3%) | - | - |
| Dec 2014 | -$18.88 M(+26.2%) | - | - |
| Dec 2013 | -$14.96 M(+66.5%) | - | - |
| Dec 2012 | -$8.98 M(+1.1%) | - | - |
| Dec 2011 | -$8.89 M(-34.1%) | - | - |
| Dec 2010 | -$13.48 M(+27.8%) | - | - |
| Dec 2009 | -$10.55 M(-8.4%) | - | - |
| Dec 2008 | -$11.52 M(+3.1%) | - | - |
| Dec 2007 | -$11.17 M(+44.8%) | - | - |
| Dec 2006 | -$7.72 M(+23.4%) | - | - |
| Dec 2005 | -$6.25 M(+0.7%) | - | - |
| Dec 2004 | -$6.21 M(+30.0%) | - | - |
| Dec 2003 | -$4.77 M(+47.8%) | - | - |
| Dec 2002 | -$3.23 M(-26.6%) | - | - |
| Dec 2001 | -$4.40 M(+7.7%) | - | - |
| Dec 2000 | -$4.08 M(+15.9%) | - | - |
| Dec 1999 | -$3.52 M(+11.6%) | - | - |
| Dec 1998 | -$3.16 M(-11.5%) | - | - |
| Dec 1997 | -$3.57 M(+67.5%) | - | - |
| Dec 1996 | -$2.13 M(+47.8%) | - | - |
| Dec 1995 | -$1.44 M | - | - |
FAQ
- What is Silence Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Silence Therapeutics?
- What is Silence Therapeutics annual EBIT year-on-year change?
- What is Silence Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Silence Therapeutics?
- What is Silence Therapeutics quarterly EBIT year-on-year change?
- What is Silence Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Silence Therapeutics?
- What is Silence Therapeutics TTM EBIT year-on-year change?
What is Silence Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SLN is -$63.32 M
What is the all time high annual EBIT for Silence Therapeutics?
Silence Therapeutics all-time high annual earnings before interest & taxes is -$1.44 M
What is Silence Therapeutics annual EBIT year-on-year change?
Over the past year, SLN annual earnings before interest & taxes has changed by +$727.70 K (+1.14%)
What is Silence Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SLN is -$6.66 M
What is the all time high quarterly EBIT for Silence Therapeutics?
Silence Therapeutics all-time high quarterly earnings before interest & taxes is -$4.23 M
What is Silence Therapeutics quarterly EBIT year-on-year change?
Over the past year, SLN quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Silence Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SLN is -$61.57 M
What is the all time high TTM EBIT for Silence Therapeutics?
Silence Therapeutics all-time high TTM earnings before interest & taxes is -$12.12 M
What is Silence Therapeutics TTM EBIT year-on-year change?
Over the past year, SLN TTM earnings before interest & taxes has changed by $0.00 (0.00%)